Size exclusion chromatography as green support for forced degradation study of adalimumab
Size exclusion chromatography (SEC) has become a powerful tool for analysing size variants of biologic drugs in their native form. Modern SEC can be defined by the use of chromatographic columns packed with sub-3 µm particles, allowing an increase in method throughput compared to that of conventiona...
Saved in:
Main Authors: | Kovačić Jelena, Klarić Daniela Amidžić, Turk Nikša, Mornar Ana |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2023-0044 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics
by: Jelena Kovačić, et al.
Published: (2025-01-01) -
Adalimumab-induced optic neuropathy in a patient with Behçet’s syndrome
by: Sofia Miranda, et al.
Published: (2025-01-01) -
Tuberculosis of the tongue in a patient under treatment with adalimumab
by: Cintia Mussi Milani, et al.
Published: (2024-12-01) -
Development and validation of a simple and sensitive size-exclusion chromatography method for quantitative determination of heparin in pharmaceuticals
by: Matanović Maja Radivojša, et al.
Published: (2015-03-01) -
Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
by: Brusač Edvin, et al.
Published: (2019-12-01)